(2-Methoxy-4-methylpyridin-3-yl)boronic acid

Catalog No.: 
ACBEGN163
CAS No.: 
1029654-21-4
Molecular Formula: 
C7H10BNO3
Molecular Weight: 
166.97
(2-Methoxy-4-methylpyridin-3-yl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$382.00InquiryInquiry
250mg95%$743.00InquiryInquiry
1g95%$2822.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2-Methoxy-4-methylpyridin-3-yl)boronic acid
IUPAC Name(2-methoxy-4-methylpyridin-3-yl)boronic acid
MDL No.MFCD07374996
Molecular FormulaC7H10BNO3
Molecular Weight166.97
SMILESCC1=C(B(O)O)C(OC)=NC=C1
InChI KeyAJLXSLVBLSRPSQ-UHFFFAOYSA-N
Synonym2-Methoxy-4-methylpyridine-3-boronic acid;(2-methoxy-4-methylpyridin-3-yl)boronic acid;Boronic acid, B-(2-methoxy-4-methyl-3-pyridinyl)-
CAS No.1029654-21-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACBEGN163 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBEGN163 route product structure diagram
    ACBEGN1631029654-21-4
Inquiry

2. ACBEGN163 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBEGN163 route product structure diagram
    ACBEGN1631029654-21-4
Inquiry

3. ACBEGN163 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZEQW943 route compound structure diagram
    ACZEQW9431420998-43-1In Stock
  2. Then
  3. ACBEGN163 route product structure diagram
    ACBEGN1631029654-21-4
Inquiry

Comments (0)